DIABETES MELLITUS, TYPE 1
Clinical trials for DIABETES MELLITUS, TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new DIABETES MELLITUS, TYPE 1 trials appear
Sign up with your email to follow new studies for DIABETES MELLITUS, TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CRISPR's diabetes cell therapy trial ends early
Disease control TerminatedThis early-stage study tested a new cell therapy called VCTX211 in 5 people with long-standing type 1 diabetes. The goal was to see if the implanted cells could safely help the body produce its own insulin again. The trial was stopped early, and results are not yet available.
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New shot aims to save Insulin-Making cells in type 1 diabetes
Disease control TerminatedThis study tested an experimental drug called TOL-3021 in people with type 1 diabetes to see if it could help preserve the body's ability to produce insulin. Participants received either the drug or a placebo over 24 weeks, with follow-up for safety. The trial was stopped early, …
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE2 • Sponsor: Tolerion, Inc. • Aim: Disease control
Last updated May 26, 2026 05:09 UTC
-
Promising diabetes delay study halted due to lack of volunteers
Disease control TerminatedThis study tested a low dose of a medicine called ATG to see if it could delay or prevent type 1 diabetes in people at high risk. Only 2 people joined before the study was stopped early because not enough volunteers signed up. The goal was to measure how long it took for diabetes…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Can two drugs stop a dangerous diabetes complication?
Knowledge-focused TerminatedThis study aimed to find a practical way to prevent hypoglycemia unawareness, a dangerous condition where people with diabetes can't feel low blood sugar. Researchers tested whether a naloxone nasal spray and a drug called diazoxide could help the body respond better to low blood…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE4 • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC